Most of Europe’s 30 million rare disease patients struggle to access information and care simply because of where they live.  

 

While Europe is making great strides in rare disease research, diagnostics and patient advocacy, treatment distribution remains a huge obstacle. 

sponsored content from sanofi  |  RARE DISEASE REALITIES

Gesture

oK

Advance the story by clicking on the arrows above, or with the arrows on your keyboard.

Rectangle, Sleeve

oK

Advance the story by tapping on the arrow below.

These stories are better experienced on desktop.

To continue in mobile mode, click below.

oK

This experience has sound.

Headphones are recommended.

oK

(if you do not wish for sound, mute your speakers now)